Population-Based Analysis of Class Effect of β Blockers in Heart Failure
- 15 April 2011
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 107 (8), 1196-1202
- https://doi.org/10.1016/j.amjcard.2010.12.017
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart FailureCirculation, 2002
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureThe New England Journal of Medicine, 2001
- Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart FailureJAMA, 2000
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- Prognostic Value of Bisoprolol-Induced Hemodynamic Effects in Heart Failure During the Cardiac Insufficiency BIsoprolol Study (CIBIS)Circulation, 1997
- Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart FailureCirculation, 1996
- Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart FailureCirculation, 1996
- Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart FailureCirculation, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureThe New England Journal of Medicine, 1996
- A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.Circulation, 1994